• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

GRN No. 1274

2'-fucosyllactose

Intended Use: Intended for use as an ingredient in non-exempt infant formula for term infants and formula for young children (>12 months) at a maximum use level of 2.4 g/L as consumed, and in other food categories at maximum levels up to 600 g/L. Tianjin states that the use of 2′-FL in non-exempt infant formula is not restricted to any specific protein base (e.g., cow milk-based, soy-based).
Basis: Scientific procedures
Notifier: Tianjin Hesheng Biotechnology Co., Ltd.
Notifier Address: No. 1201, Building 6, Artificial Intelligence Industrial Park
Xiqing Economic and Technological Development Zone, Tianjin
CHINA
FDA's Letter: Pending
-
-